InfuSystems HoldingsINFU +11.05%86 Pretax Margin % is 4.21% as of Mar. 2026, which is 212% above its 10-year median of 1.35. GuruFocus rates INFU with a GF Score™ of 86/100 and a GF Value™ of $9.44 (Fairly Valued). The stock has 3 warning signs investors should review. Among 818 Medical Devices & Instruments companies, InfuSystems Holdings ranks better than 62.96% on this metric.
The historical rank and industry rank for InfuSystems Holdings's Pretax Margin % or its related term are showing as below:
INFU'
s Pretax Margin % Range Over the Past 10 Years
Min: -7.4 Med: 1.35 Max: 8.28
Current: 8.28
INFU's Pretax Margin % is ranked better than 62.96% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 2.505
vs INFU: 8.28
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
InfuSystems Holdings Pretax Margin % Related Terms
InfuSystems Holdings Pretax Margin % Historical Data
* Premium members only.
The historical data trend for InfuSystems Holdings's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INFU vs TANAF, INGN, LUCD: Pretax Margin % Comparison
For the Medical Devices subindustry, InfuSystems Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InfuSystems Holdings Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where InfuSystems Holdings's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InfuSystems Holdings (INFU) has a Pretax Margin % of 4.21% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on InfuSystems Holdings and its competitors. This is 212% above median its historical median of 1.35. According to the industry distribution chart, InfuSystems Holdings ranks #303 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 37%.
Is InfuSystems Holdings' Pretax Margin % too high?
InfuSystems Holdings' current Pretax Margin % of 4.21% is 212% above median its 10-year median of 1.35. The Medical Devices & Instruments industry median Pretax Margin % is 2.51. InfuSystems Holdings' value of 4.21% is 68.1% above this industry median. Based on the distribution chart, InfuSystems Holdings ranks #303 out of 818 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, InfuSystems Holdings has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does InfuSystems Holdings' Pretax Margin % compare to TANAF and INGN?
According to the Medical Devices & Instruments industry distribution chart, InfuSystems Holdings ranks #303 out of 818 companies for Pretax Margin %. This puts InfuSystems Holdings in the upper half of its industry. The industry median Pretax Margin % is 2.51. InfuSystems Holdings' value of 4.21% is 68.1% above this benchmark. While the company's 10-year median is 1.35 vs. the industry median of 2.51, InfuSystems Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.51, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InfuSystems Holdings's current Pretax Margin % of 4.21% is 68.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on InfuSystems Holdings and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InfuSystems Holdings's current Pretax Margin % is 4.21%, which is 212% above median its own 10-year median of 1.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InfuSystems Holdings stock overvalued right now?
Based on GuruFocus' analysis, InfuSystems Holdings (INFU) is currently considered Fairly Valued. The stock's GF Value™ is $9.44, compared to a current price of $10.05 — trading 6.5% above its estimated fair value. The current Pretax Margin % is 4.21%, which is 212% above median its 10-year median of 1.35 and 68.1% above the Medical Devices & Instruments industry median of 2.51. InfuSystems Holdings' overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For InfuSystems Holdings (INFU), the current Pretax Margin % is 4.21% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InfuSystems Holdings (INFU) Overvalued in 2026?
Based on GuruFocus' analysis, InfuSystems Holdings stock appears to be overvalued.
The current stock price of $10.05 is trading 6.5% above its estimated GF Value™ of $9.44.
GuruFocus considers InfuSystems Holdings to be Fairly Valued.
Key valuation signals for INFU:
Pretax Margin %: 4.21% (212% above median its 10-year median of 1.35)
GF Value™: $9.44 vs. price of $10.05 (6.5% above fair value)
Industry Position: 68.1% above the Medical Devices & Instruments median (#303 of 818)
No single metric tells the full story. See the INFU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
86GF Score
Get the complete analysis for INFU
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INFU has been successfully added to your 
